UltraGreen.ai acquires Perfusion Tech
The acquisition is set to create a comprehensive surgical intelligence platform that offers objective and standardised perfusion assessments. This innovation is expected to reduce surgical risks and improve clinical outcomes across various procedures, including colorectal, reconstructive, and vascular surgeries. Additionally, the integration opens new commercial opportunities in chronic wound care and diabetic foot ulcer treatment, potentially benefiting over 18 million patients globally.